Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

21 November 2023

Global health warning as antibiotic-resistant bacteria threatens new crisis

In an article for Express, Isabelle Durso writes about the urgent need for pharmaceutical companies to develop new antibiotics amid growing antibiotic resistance (AMR). The article references the Foundation's work on AMR.

Direct links

Read the full article

Durso writes about the escalating threat of AMR and highlights criticism toward pharmaceutical companies for insufficient research into new antibiotic drugs. She discusses the danger posed by antibiotic-resistant bacteria and the global impact of AMR, especially on people living in low- and middle-income countries, which rely on pharmaceutical companies for medication.

She points out the Foundation's call for heightened research efforts, and references some of its work on AMR.

"The Access to Medicine Foundation, based in the Netherlands, has said that drug resistance is a major threat and has called for more research into new antibiotic drugs."

Cross-sector Research

Learn more about our work on AMR
Featured News

The 2021 AMR Benchmark pinpointed opportunities for companies. Did they take them?

21 November 2023
News

What steps are companies taking to help curb AMR by manufacturing responsibly?

22 August 2023

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved